Form 4 for MLAB MESA LABORATORIES INC /CO/
Accepted 2021-12-10 00:00:00 ET · period of report 2021-12-10 · accession 0001228924-21-000082 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-12-10 | 2021-12-10 | MLAB | Sakys John | CFO | M - OptEx | $97.05 | +1,758 | 9,272 | +23% | +$170.6K |
| D | 2021-12-10 | 2021-12-10 | MLAB | Sakys John | CFO | S - Sale+OE | $324.74 | -1,758 | 7,514 | -19% | -$570.9K |
| DM | 2021-12-10 | 2021-12-10 | MLAB | Sakys John | CFO | X - OptEx | $0.00 | -1,758 | 29.9K | -6% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-10 | M | A | 158 | $89.70 | 7,672 | D | — | — | |
| 2 | Common | Common Stock | 2021-12-10 | M | A | 1,600 | $97.78 | 9,272 | D | — | — | |
| 3 | Common | Common Stock | 2021-12-10 | S | D | 1,758 | $324.74 | 7,514 | D | — | — | (F3) Sale reported on this Form 4 was effected pursuant to a Rule 10B5-1 trading plan adopted by the reporting person on March 1, 2021 |
| 4 | Derivative | Non Qualified Stock Option | 2021-12-10 | X | D | 1,600 | $0.00 | 28,271 | D | $97.78 · 2017-04-01 to 2022-04-01 | 1,600 Common Stock | (F2) 1/5 exercisable on each anniversary date of the 04-01-2016 grant date |
| 5 | Derivative | Incentive Stock Option | 2021-12-10 | X | D | 158 | $0.00 | 29,871 | D | $89.70 · 2015-04-01 to 2022-04-01 | 158 Common Stock | (F1) 1/7 exercisable on each anniversary date of the 04/01/2014 grant date |